A frosted glass brain sculpture on a travertine block, beside a blood spot card and two amber omega-3 capsules.

Diagnostic menu


Brain Health & Cognitive Resilience

Connect nutritional biomarkers with cognitive performance.

Blood spot card collected at home, plus a 10–15-minute online cognitive assessment.

  • Two partsBlood spot profile and online cognitive assessment
  • 5 + 5Nutritional measures and cognitive metrics in the report
  • One reportBrought together in a Brain Readiness Score

Precision health · Brain health

What your report brings together

A two-part assessment combining a dried blood spot fatty-acid profile with an online cognitive test. Results bring nutritional status and measured cognitive performance into one profile for informed discussion and follow-up.

The fatty-acid profile measures nutritional biomarkers. The online cognitive scores describe performance on the assessed tasks. Read together, and repeated over time, they give a structured starting point for discussion and follow-up.

  • 01
    • Fatty-acid analysis from a small blood sample collected on a blood spot card
    • Five selected nutritional measures are currently included in the report
  • 02
    • Online testing across cognitive domains, with normatively scored results
    • The current report groups cognition into five metrics for repeat comparison
  • 03
    • Repeat results can support review of nutritional changes and cognitive performance
    • Changes require interpretation in light of measurement variability and repeat-testing effects

What is measured

Measurement and interpretation

The analytical panel covers 32 blood biomarkers. Five selected measures are currently included in the report; the full analytical panel and the report have different scopes. Cognition is reported as five metrics in three groups.

  • Omega-3 status.
  • Arachidonic acid relative to eicosapentaenoic acid. Fatty-acid context, not an inflammation assay.
  • Docosahexaenoic acid status.
  • Trans fatty-acid profile.
  • A selected saturated fatty acid.
  • Learning, retention and recall.
  • Processing speed and cognitive flexibility.
  • Sustained attention and executive function.

Inside the report

What the report shows

One connected report

Nutritional profile · blood spotCognitive profile · online assessmentOmega-3 IndexAA:EPA ratioDHA IndexTrans Fat IndexPalmitic acidMemory capacitySustained attentionProcessing speedCognitive flexibilityExecutive functionBrainReadiness ScoreSummary, not a diagnostic scoreWellness guidance · Repeat comparisons
Report structure illustration, no patient values shown. Five nutritional biomarkers and five cognitive metrics are summarised in an overall Brain Readiness Score; the individual measures are kept alongside it. The score is not a diagnostic score.

Panel and report have different scopes

Fatty-acid analysis
32blood biomarkers in the analytical panel
5selected measures currently in the report
  • Omega-3 Index
  • AA:EPA ratio
  • DHA Index
  • Trans Fat Index
  • Palmitic acid
Cognitive assessment
6domains listed in the 2026 overview
  • Working memory
  • Recall memory
  • Sustained attention
  • Processing speed
  • Cognitive flexibility
  • Executive function
5metrics in the current report: working and recall memory are reported together as memory capacity
  • Memory capacity
  • Sustained attention
  • Processing speed
  • Cognitive flexibility
  • Executive function
The laboratory analyses 32 blood biomarkers; five selected measures are currently included in the report. Current reporting uses five cognitive metrics; the 2026 overview lists working and recall memory separately within six domains.

What you get

From patient testing to practice follow-up

    • At home: blood spot collection takes approximately 2–3 minutes, and the sample is mailed for analysis
    • A 10–15-minute online assessment on your own device, in a quiet setting
    • One connected report: Brain Readiness Score, five nutritional biomarkers, five cognitive metrics, wellness guidance and repeat comparisons
    • Complete both assessments; review the score, individual results and guidance
    • Compare the same measures at follow-up
    • Practice branding and a selected report format
    • Request a sample report and professional account to discuss formats, kits, patient testing and portal access

How it works

From assessment to follow-up

  1. 01A small blood sample on a blood spot card, at home, mailed for analysis.
  2. 02Normatively scored cognitive tests on your own device.
  3. 03Nutritional and cognitive results in one report.
  4. 04Nutrition and supplementation decisions are individualised.
  5. 05Timing should reflect the individual objective.

Two assessments, one profile

Part 01 · at homeBlood spot card≈ 2–3 minutesMailed forfatty-acid analysisPart 02 · own deviceOnline assessment10–15 minutes, quiet settingNormativelyscored resultsOnereportIndividualplanReassess where appropriate (≈ 90 days proposed)
Blood spot collection takes approximately 2–3 minutes at home; the card is mailed for analysis. The online assessment takes 10–15 minutes on the patient’s own device, in a quiet setting. The source programme proposes approximately 90-day repeat testing; this interval is not evidence of disease prevention or guaranteed benefit.

Method and evidence

Research and scientific context

  • A 2013 cross-sectional study assessed 78 deployed U.S. service members using blood spot omega-3 analysis and computerised cognitive tests. Sleep and psychological measures were included. Higher omega-3 status was associated with executive function and cognitive flexibility. [1]
  • Participants were recruited with mild-to-moderate depressive symptoms, limiting generalisability. One time point, no intervention or longitudinal product evaluation. Association only; no current-product validation or treatment evaluation. [1]
  • Blood spot estimates of five nutritional biomarkers are combined with five norm-referenced cognitive metrics. Repeated reports retain the individual measures alongside the overall Brain Readiness Score.
  • The evidence described for this assessment includes observational fatty-acid research and unpublished programme data. Associations between fatty-acid status and health outcomes do not establish that testing or supplementation prevents disease or improves cognition.
  1. Johnston DT, Deuster PA, Harris WS, MacRae H, Dretsch MN. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers. Nutritional Neuroscience. 2013;16(1):30–38. doi:10.1179/1476830512Y.0000000025 · PMID: 22748167

What the cited study can and cannot show

  • 78 participantsA specific deployed military population
  • One time pointNo intervention or longitudinal product evaluation
  • Two domainsExecutive function and cognitive flexibility associations
What it shows

An association between higher omega-3 status and executive function and cognitive flexibility

What it does not show

That testing or supplementation prevents disease or improves cognition

Validation of the current product

A 2013 cross-sectional study of 78 deployed U.S. service members recruited with mild-to-moderate depressive symptoms. Association only; no current-product validation or treatment evaluation. [1]

Clinical value

Repeat testing and follow-up

The source programme proposes approximately 90-day repeat testing. Timing should reflect the individual objective; this interval is not evidence of disease prevention or guaranteed benefit.

  1. 01Complete both assessments and review the score, the individual results and the guidance.
  2. 02Agree nutrition and supplementation decisions individually, in the wider clinical context.
  3. 03Compare the same measures at follow-up. Retest changes alone do not establish treatment efficacy.

Measure → Intervene → Re-measure → Verify

White-label opportunity

Your programme. Your brand. Our infrastructure.

Brain Health & Cognitive Resilience can be integrated into healthcare, longevity and preventive-health programmes as a branded or co-branded testing pathway, without building the laboratory infrastructure behind it.

  • Branded test kits and packaging
  • Integration into existing clinic or longevity programmes
  • Remote sample collection
  • Laboratory analysis
  • A patient-facing experience in your name
  • Results delivered into your preferred reporting environment
  • Repeat testing and longitudinal programmes
  • Sample collection at home, outside the clinic.
  • Nutritional biomarkers and measured cognitive performance, from a blood spot and an online test.
  • Repeat testing to follow change over time.

Limitations

Interpretation boundaries

The fatty-acid profile measures nutritional biomarkers; it does not directly measure brain tissue, neuroinflammation or neuronal damage. AA:EPA provides fatty-acid context, not an inflammation assay. Cognitive percentiles compare performance with a normative population; they are not brain ages or disease-risk predictions. The Brain Readiness Score summarises nutritional and cognitive results; it is not a diagnostic score.

This assessment does not establish or exclude dementia, Alzheimer’s disease or another neurological condition. Cognitive concerns require clinical evaluation. Brain Health & Cognitive Resilience provides general-wellness information and does not diagnose, predict, prevent, treat or rule out disease. Availability and regulatory status vary by market.

Download fact sheet (PDF)Back to the diagnostic menu

Contact

Thirty minutes, and you will know whether this fits your clinic.

Tell us how your clinic works today and which patients you see. We will go through the portfolio, what can be offered in your market, and what your team would need from us.

Book an introductory meeting · Step 1 of 2

Who are we talking to?

Choose the one closest to you, so the right person from our team takes the meeting.